引用本文:吴旭斌,伍广伟(综述),林英忠(审校).噻唑烷二酮类药物的血管保护作用研究进展[J].中国临床新医学,2010,3(2):201-204.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1285次   下载 1095 本文二维码信息
码上扫一扫!
分享到: 微信 更多
噻唑烷二酮类药物的血管保护作用研究进展
吴旭斌,伍广伟(综述),林英忠(审校)
530021 南宁,广西壮族自治区人民医院心内科
摘要:
[摘要] 噻唑烷二酮类药物(Thiazolidinediones,TZDs)是人工合成的高亲合性的过氧化物酶体增殖物激活受体γ(Peroxisome proliferator-activated receptors,PPARs)配体。TZDs除通过改善胰岛素抵抗、降糖作用外,尚可通过改善内皮功能、抗炎、抑制平滑肌增生和新生内膜形成、预防动脉再狭窄等方面发挥血管保护作用。
关键词:  噻唑烷二酮类药物  过氧化物酶体增殖物激活受体γ  血管  保护作用
DOI:10.3969/j.issn.1674-3806.2010.02.44
分类号:R 587
基金项目:
Protective effects of thiazolidinediones in the Vasculature
WU Xu-bin, WU Guang-wei, LIN Ying-zhong
Department of Cardiology, the People′s Hospital of Guangxi Zhuang Autonomous Regions, Nanning 530021,China
Abstract:
[Abstract] The thiazolidinediones(TZDs) are peroxisome proliferator-activated receptor (PPAR)-γ agonists. In addition to improving insulin sensitivity and glycemic control, TZDs also play critical roles in the vasculature by improving endothelial dysfunction, decreasing the expression of several inflammatory mediators, inhibiting the proliferation and migration of vascular smooth muscle cells and the development of restenosis after vascular interventions.
Key words:  Thiazolidinediones  Peroxisome proliferator-activated receptors  Vasculature  Protective effects